Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Dendritic Cell Immunotherapy in Colorectal Cancer
NCT03214939Phase 1Unknown
- Sponsor
- Research Institute of Fundamental and Clinical Immunology
- Start
- Sep 2016
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in colorectal cancer (CRC), sponsored by Research Institute of Fundamental and Clinical Immunology. Primary endpoint: Cytotoxicity at 6 months. Status: unknown.
02
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03214939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03214939.